Randomized, placebo-controlled, double blinded study to investigate the efficacy and safety of a 24-week inhalation treatment with glutathione in cystic fibrosis patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Glutathione (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 10 Jul 2012 Biomarkers information updated
- 18 Oct 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Planned number of patients 138 added as reported by ClinicalTrials.gov.